T0	Participants 73 115	gastric cancer of the cardia or subcardia:
T1	Participants 293 335	gastric cancer of the cardia or subcardia.
T2	Participants 481 574	Between July, 1995, and December, 2003, 167 patients were enrolled from 27 Japanese hospitals
T3	Participants 831 865	The projected sample size was 302.
T4	Participants 866 1063	After the first interim analysis, the predicted probability of LTA having a significantly better overall survival than TH at the final analysis was only 3.65%, and the trial was closed immediately.
T5	Participants 1555 1602	patients with cancer of the cardia or subcardia